Effects of supraspinal orphanin FQ/nociceptin.
The first reported behavioral action of the endogenous ligand for the "orphan" opioid receptor was a seemingly paradoxical increased sensitivity to nociception (i.e. hyperalgesia) after supraspinal injection into the cerebral ventricles of mice. In the continuing absence of an appropriate in vivo receptor antagonist, studies attempting to define the role of orphanin FQ/nociceptin (OFQ/N) in pain modulation and other behaviors have also featured central injection of peptide. This article reviews the findings of such studies. There appears to be concordance around the observation of anti-opioid actions of supraspinally injected OFQ/N, whereas the observations of hyperalgesia and/or analgesia are much less clear. A portion of the discrepant data may be explained in terms of methodological issues, stress-induced analgesia accompanying experimental protocols, and genotypic variation among subjects. Clarification of OFQ/N's role in nociception, as with other putative biologic functions, will probably depend upon the availability of a selective receptor antagonist.
Grisel
J E
JE
Department of Psychology, Furman University, 29613, Greenville, SC, USA.
Mogil
J S
JS
D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D005838:Genotype; D051379:Mice; D018345:Mice, Knockout; D018847:Opioid Peptides / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000235:genetics / Q000494:pharmacology*; D010455:Peptides / Q000737:chemistry / Q000494:pharmacology; D010641:Phenotype; D051381:Rats; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000097629:Nociceptin
D000700:Analgesics; D018847:Opioid Peptides; D010455:Peptides; D014665:Vasodilator Agents; D000097629:Nociceptin